Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12.
Close to 60% of patients in U.S. national ambulatory survey were prescribed two or more psychotropic medications in 2005, a sharp rise from the 42.6% seen in 1996.
